Detalhe da pesquisa
1.
Exploring the Combined Action of Adding Pertuzumab to Branded Trastuzumab versus Trastuzumab Biosimilars for Treating HER2+ Breast Cancer.
Int J Mol Sci
; 25(7)2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38612751